Stock Analysis | Agilent Technologies Outlook - Mixed Signals Amid Volatile Market Conditions
Market Snapshot
Headline takeaway: Agilent TechnologiesA-- is facing mixed signals with weak technical indicators but strong money-flow trends. Stance: Cautious.
News Highlights
Recent news includes Walmart’s embrace of agentic AI, Lifeway Foods’ retail expansion, and Modine’s $112 million acquisition of a specialty heating business. These developments could indirectly influence investor sentiment in the broader market, but direct impacts on Agilent Technologies remain unclear for now.
Analyst Views & Fundamentals
On average, analysts give Agilent Technologies a simple mean rating of 3.50 and a performance-weighted rating of 3.45. The ratings are relatively consistent, with no major dispersion. However, the recent price trend has seen a 5.13% rise, which contrasts with the neutral to bearish technical outlook.
Key Fundamental Values
- Price-to-Sales (PS): 22.77% — Internal diagnostic score: 2 (weak).
- Basic Earnings per Share (YoY growth rate): -16.52% — Internal diagnostic score: 1 (negative).
- Net Cash Flow from Operating Activities / Operating Revenue: 19.47% — Internal diagnostic score: 2 (neutral).
- Diluted Earnings per Share (YoY growth rate): -16.59% — Internal diagnostic score: 1 (negative).
- EBIT / Total Operating Revenue: 19.56% — Internal diagnostic score: 2 (neutral).
Money-Flow Trends
Big-money investors and retail flows show a negative overall trend. Specifically:
- Small-cap inflow ratio: 49.94%
- Medium-cap inflow ratio: 48.73%
- Large-cap inflow ratio: 46.03%
- Extra-large-cap inflow ratio: 50.27%
The internal diagnostic score for fund-flow trends is 7.85 (good), suggesting strong inflows despite the technical weakness.
Key Technical Signals
Agilent Technologies is currently showing weak technical indicators. The internal diagnostic score for the technical side is 3.23, indicating a “weak” technical outlook. Key signals include:
- Williams %R (WR) Overbought: Internal diagnostic score: 1.9 (weak). This indicator has historically appeared 45 times, with an average return of 0.13% and a win rate of 42.22%.
- Earnings Release Date: Internal diagnostic score: 4.56 (moderate). This signal has appeared 4 times, with an average return of 1.38% and a win rate of 50.0%.
Recent indicators by date:
- August 22, 2025: WR Overbought
- September 2, 2025: WR Overbought
- August 28, 2025: WR Overbought
- August 27, 2025: Earnings Release Date
- August 29, 2025: WR Overbought
Technical insights: The market is in a volatile state with unclear direction. Bearish signals dominate (1 bearish vs 0 bullish), and recent technical signals are scarce, suggesting a relatively calm but weak trend.
Conclusion
Given the weak technical signals and mixed fundamentals, it may be wise to consider waiting for a pull-back or avoiding new long positions. The strong fund-flow trends suggest underlying support, but the bearish indicators imply risk. Watch the next earnings release and monitor the WR Overbought pattern for potential trading cues.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet